Neurotensin: A novel mediator of ovulation?


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
04 2021
Historique:
received: 19 11 2020
revised: 11 02 2021
accepted: 12 02 2021
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 16 7 2021
Statut: ppublish

Résumé

The midcycle luteinizing hormone (LH) surge initiates a cascade of events within the ovarian follicle which culminates in ovulation. Only mural granulosa cells and theca cells express large numbers of LH receptors, and LH-stimulated paracrine mediators communicate the ovulatory signal within the follicle. Recent reports identified the neuropeptide neurotensin (NTS) as a product of granulosa cells. Here, we demonstrate that granulosa cells were the primary site of NTS expression in macaque ovulatory follicles. Granulosa cell NTS mRNA and protein increased after human chorionic gonadotropin (hCG) administration, which substitutes for the LH surge. To identify ovulatory actions of NTS, a NTS-neutralizing antibody was injected into preovulatory macaque follicles. hCG administration immediately followed, and ovaries were removed 48 hours later to evaluate ovulatory events. Follicles injected with control IgG ovulated normally. In contrast, 75% of NTS antibody-injected follicles failed to ovulate, containing oocytes trapped within unruptured, hemorrhagic follicles. Serum progesterone was unchanged. Of the three NTS receptors, SORT1 was highly expressed in follicular granulosa, theca, and endothelial cells; NTSR1 and NTSR2 were expressed at lower levels. Excessive blood cells in NTS antibody-injected follicles indicated vascular anomalies, so the response of monkey ovarian endothelial cells to NTS was evaluated in vitro. NTS stimulated endothelial cell migration and capillary sprout formation, consistent with a role for NTS in vascular remodeling associated with ovulation. In summary, we identified NTS as a possible paracrine mediator of ovulation. Further investigation of the NTS synthesis/response pathway may lead to improved treatments for infertility and novel targets for contraception.

Identifiants

pubmed: 33710668
doi: 10.1096/fj.202002547RR
pmc: PMC8314182
mid: NIHMS1715439
doi:

Substances chimiques

Chorionic Gonadotropin 0
Neurotensin 39379-15-2
Luteinizing Hormone 9002-67-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e21481

Subventions

Organisme : NICHD NIH HHS
ID : P01 HD071875
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD097675
Pays : United States

Informations de copyright

© 2021 Federation of American Societies for Experimental Biology.

Références

Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Mol Pharmacol. 2001 Dec;60(6):1392-8
pubmed: 11723247
Endocrinology. 1973 Nov;93(5):1140-7
pubmed: 4205042
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10288-93
pubmed: 10944203
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1971-1982
pubmed: 28323945
Hum Reprod. 2016 Feb;31(2):436-44
pubmed: 26740577
Oncotarget. 2014 Sep 30;5(18):8252-69
pubmed: 25249545
FEBS Lett. 1997 Dec 1;418(3):341-5
pubmed: 9428741
J Reprod Dev. 2015;61(4):297-303
pubmed: 25994242
Trends Neurosci. 2012 Apr;35(4):261-70
pubmed: 22341525
Neuropharmacology. 2012 Jan;62(1):278-88
pubmed: 21807005
Int J Biochem Cell Biol. 2008;40(10):2296-302
pubmed: 18456542
Tumour Biol. 2015 Aug;36(8):6053-62
pubmed: 25724188
Mol Inform. 2016 Jan;35(1):19-24
pubmed: 27491650
Hum Reprod Update. 2015 Sep-Oct;21(5):652-70
pubmed: 26025453
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1897-901
pubmed: 8700855
PLoS One. 2014 Jan 08;9(1):e83098
pubmed: 24416154
Oncogene. 2007 Feb 1;26(5):745-56
pubmed: 16862179
Front Endocrinol (Lausanne). 2019 Nov 07;10:727
pubmed: 31787928
Endocrinology. 2018 Sep 1;159(9):3209-3218
pubmed: 30010832
Reprod Biol. 2013 Dec;13(4):259-71
pubmed: 24287034
Avicenna J Med Biotechnol. 2014 Jul;6(3):169-77
pubmed: 25215181
Biochem J. 1993 Apr 1;291 ( Pt 1):225-33
pubmed: 8471039
Peptides. 2006 Oct;27(10):2476-87
pubmed: 16919370
Contraception. 2005 Apr;71(4):239-48
pubmed: 15792643
J Biol Chem. 1973 Oct 10;248(19):6854-61
pubmed: 4745447
Front Neurosci. 2016 Nov 24;10:542
pubmed: 27932946
Gene. 2019 Mar 1;687:143-150
pubmed: 30359740
Endocrinology. 2018 Feb 1;159(2):710-722
pubmed: 29095972
Reprod Biol Endocrinol. 2018 May 1;16(1):43
pubmed: 29716588
Endocrinology. 2014 Apr;155(4):1466-75
pubmed: 24506073
Mol Hum Reprod. 2014 Sep;20(9):844-9
pubmed: 24874553
Biol Reprod. 2015 Jan;92(1):15
pubmed: 25376231
J Reprod Dev. 2016 Aug 25;62(4):409-14
pubmed: 27210588
Nat Rev Mol Cell Biol. 2011 Aug 23;12(9):551-64
pubmed: 21860391
Endocrinology. 1993 Jun;132(6):2491-7
pubmed: 8504752
Eur J Pharmacol. 2017 Jun 15;805:1-13
pubmed: 28341345
Endocr Rev. 2019 Apr 1;40(2):369-416
pubmed: 30496379
Hum Reprod. 2005 Jun;20(6):1485-92
pubmed: 15774546
Cancer Res. 2006 Jun 15;66(12):6243-9
pubmed: 16778199
J Clin Endocrinol Metab. 2006 Aug;91(8):3131-7
pubmed: 16705076
Biol Reprod. 2014 Aug;91(2):53
pubmed: 25031361
J Clin Endocrinol Metab. 2005 Feb;90(2):1021-7
pubmed: 15522934
BMC Cancer. 2011 Oct 02;11:421
pubmed: 21961726
Recent Prog Horm Res. 1981;37:183-298
pubmed: 7025133
Endocr Rev. 2003 Aug;24(4):428-65
pubmed: 12920150
Reprod Biol Endocrinol. 2015 Aug 05;13:84
pubmed: 26242217
Endocrinology. 1996 Jan;137(1):198-209
pubmed: 8536613
Front Endocrinol (Lausanne). 2012 Nov 26;3:143
pubmed: 23230428
Biochim Biophys Acta. 2013 Mar;1833(3):573-82
pubmed: 23220008
Oncotarget. 2014 Sep 30;5(18):8235-51
pubmed: 25249538
Biol Reprod. 2016 May;94(5):109
pubmed: 26985003
Neurosci Lett. 1987 Jan 27;73(3):220-4
pubmed: 3561863
Endocrinology. 1989 Oct;125(4):1959-66
pubmed: 2676474
Neoplasia. 2018 Feb;20(2):175-181
pubmed: 29272741
Biol Reprod. 2005 Jun;72(6):1305-14
pubmed: 15689536
Cell Oncol. 2007;29(4):315-26
pubmed: 17641415
Hum Reprod. 2014 May;29(5):997-1010
pubmed: 24510971
Front Endocrinol (Lausanne). 2013 Mar 22;4:36
pubmed: 23526754
Nature. 2016 May 11;533(7603):411-5
pubmed: 27193687
Int J Biochem Cell Biol. 2009 Dec;41(12):2398-402
pubmed: 19891061
PLoS One. 2017 May 16;12(5):e0175842
pubmed: 28510609
Nat Rev Endocrinol. 2017 Feb;13(2):67-68
pubmed: 28059155
Regul Pept. 2011 Oct 10;170(1-3):7-17
pubmed: 21549161
Endocrinology. 1991 Dec;129(6):3200-7
pubmed: 1954899
Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E80-8
pubmed: 19861584

Auteurs

Genevieve E Campbell (GE)

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.

Hannah R Bender (HR)

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.

Grace A Parker (GA)

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.

Thomas E Curry (TE)

Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.

Diane M Duffy (DM)

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH